478 related articles for article (PubMed ID: 238629)
21. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
Minneman KP
J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
[TBL] [Abstract][Full Text] [Related]
22. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
[TBL] [Abstract][Full Text] [Related]
23. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts.
Takemoto DJ; Lee WN; Kaplan SA; Appleman MM
J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751
[TBL] [Abstract][Full Text] [Related]
25. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
26. Serum cyclic 3',5'-nucleotide phosphodiesterase in patients with various thyroid disorders.
Nagasaka A; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M; Nihei N; Nakagawa H; Ohyama T; Aono T
Enzyme; 1985; 33(1):18-24. PubMed ID: 2985379
[TBL] [Abstract][Full Text] [Related]
27. Effects of CuCl2 on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
Donnelly TE
Biochim Biophys Acta; 1978 Oct; 543(3):273-82. PubMed ID: 213129
[TBL] [Abstract][Full Text] [Related]
28. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes.
Weiss HR; Lazar MJ; Punjabi K; Tse J; Scholz PM
Eur J Pharmacol; 2003 Nov; 481(1):25-31. PubMed ID: 14637171
[TBL] [Abstract][Full Text] [Related]
29. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
30. Cyclic nucleotide phosphodiesterases of Hyalophora cecropia silkmoth fat body.
Filburn CR; Karn J; Wyatt GR
Biochim Biophys Acta; 1977 Mar; 481(1):152-63. PubMed ID: 14689
[TBL] [Abstract][Full Text] [Related]
31. Heat-stable low molecular weight form of phosphodiesterases from bovine pineal gland.
Sankaran K; Hanbauer I; Lovenberg W
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3188-91. PubMed ID: 210451
[TBL] [Abstract][Full Text] [Related]
32. Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+.
Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K
Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3526-30. PubMed ID: 4357877
[TBL] [Abstract][Full Text] [Related]
33. Cyclic nucleotide phosphodiesterase activity in bovine brain coated vesicles.
Silva WI; Schook W; Mittag TW; Puszkin S
J Neurochem; 1986 Apr; 46(4):1263-71. PubMed ID: 2869110
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
Grant PG; Colman RW
Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
[TBL] [Abstract][Full Text] [Related]
35. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
King LE; Solomon SS; Hasimoto K
J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
[TBL] [Abstract][Full Text] [Related]
36. Cyclic nucleotide phosphodiesterases in uterine development.
Stancel GM; Thompson WJ; Strada SJ
Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
[TBL] [Abstract][Full Text] [Related]
37. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma.
Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M
Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609
[TBL] [Abstract][Full Text] [Related]
38. Response of rabbit ciliary process cyclic nucleotides to specific phosphodiesterase inhibitors.
Okada K; Gregory DS
Curr Eye Res; 2000 Oct; 21(4):774-81. PubMed ID: 11120567
[TBL] [Abstract][Full Text] [Related]
39. Induction of cyclic AMP and cyclic GMP 3':5'-cyclic nucleotide phosphodiesterase activities in neuroblastoma lines under differentiating conditions.
Giorgi M; Giordano D; Caniglia C; Biagioni S; Augusti-Tocco G
Int J Dev Neurosci; 1997 Jun; 15(3):309-19. PubMed ID: 9253655
[TBL] [Abstract][Full Text] [Related]
40. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
Donnelly TE
Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
